Ex-Rabobank CEO fined $20K for withholding AML report
By 
Kyle Brasseur2022-08-19T15:58:00
The former chief executive officer of Rabobank, N.A. was fined $20,000 by the Office of the Comptroller of the Currency (OCC) last month for his alleged role in obstructing a Bank Secrecy Act (BSA) program examination.
John Ryan, CEO of Rabobank from September 2012 until December 2015, caused a material audit report to not be submitted to the OCC while it was carrying out an investigation at the bank in 2013, the agency alleged. In December 2013, Rabobank agreed to a consent order with the OCC regarding deficiencies in its BSA/anti-money laundering (AML) compliance program. The bank would be fined $50 million by the regulator in 2018 regarding the latter’s findings during that probe.
Ryan’s settlement with the OCC was reached July 28 and announced Thursday.
Related articles
-
News BriefOCC ‘reluctantly’ drops enforcement, fine against former Rabobank CCO
The Office of the Comptroller of the Currency dismissed an enforcement action and withdrew a fine against the former chief compliance officer for the now-defunct U.S. branch of Rabobank N.A.
-
PremiumNeed to know: FASB proposal on accounting for crypto assets
The Financial Accounting Standards Board issued a proposed accounting standards update to improve accounting and disclosures for certain crypto assets.
-
ArticleRabobank probed by Dutch prosecutors over potential AML violations
Rabobank, the second largest bank in the Netherlands, is being investigated by the Dutch Public Prosecution Service for potential violations of the country’s anti-money laundering/countering the financing of terrorism law.
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”